Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Nordic Society for Pediatric Hematology and Oncology
With
Oulu University Hospital
20% of children with ALL still fails to be cured. The ALL-2008 protocol is a treatment and research protocol that aims to improve the overall outcome of Nordic children and adolescents with ALL in comparison with the ALL-2000 protocol and previous NOPHO protocols.
The specific and primary objectives of the randomised study is:
1. To replace intrathecal triple (methotrexate, cytarabine and glucocorticosteroid) by intrathecal liposomal cytarabine and glucocorticosteroid during maintenance therapy in order to decrease the central nervous system relapse rate in high-risk acute lymphoblastic leukemia patients.
2. To evaluate acute and long-term toxicity in both treatment arms.
Age
1–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
High risk acute lymphoblastic leukemia
You may not be if
Age 1-18
Written informed consent has been obtained
Persistent NCI grade 3-4 neurotoxicity from previous treatments